CareDx (CDNA) Asset Writedowns and Impairment (2021 - 2025)

CareDx's (CDNA) quarterly Asset Writedowns and Impairment came in at -$2.3 million in Q4 2025, down 125.8% quarter-over-quarter from -$1.0 million in Q4 2023.

CareDx (CDNA) Asset Writedowns and Impairment (2021 - 2025) Analysis & Trends

CareDx has disclosed Asset Writedowns and Impairment across 4 years of filings, most recently posting -$2.3 million for Q4 2025.

  • Asset Writedowns and Impairment for Q4 2025 came in at -$2.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.3 million (changed N/A YoY), and the FY2022 annual result was $840000.0, down 65.53% from the prior year.
  • Asset Writedowns and Impairment came in at -$2.3 million for Q4 2025 at CareDx, down from -$1.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $2.4 million in Q4 2021 to a low of -$2.3 million in Q4 2025.
  • The 4-year median for Asset Writedowns and Impairment is $840000.0 (2022), against an average of $203800.0.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn
10 CareDx 1.17 Bn 979.60 Mn 87.33 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -2.26 Mn
Dec 31, 2025 -2.26 Mn
Dec 31, 2023 -1.00 Mn
Dec 31, 2023 -1.00 Mn
Mar 31, 2023 1.00 Mn
Mar 31, 2023 1.00 Mn
Sep 30, 2022 840,000.00
Sep 30, 2022 840,000.00
Dec 31, 2021 2.44 Mn
Dec 31, 2021 2.44 Mn